Microscopic polyangiitis

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
3 Unique IMPs
1 Commercial trials
Drug classes (ATC)
ATC code not specified 1
L Oncology (ATC L) 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Monoclonal antibody (chimeric) 1 substance
Phase II: 2 Phase IV: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

2 trials
  • Novartis Pharma AG Commercial
    IPTACOPAN
    2023-510525-15-00 9 countries 2024 n=44
    Ended
  • Charite Universitaetsmedizin Berlin KöR Academic
    IMLIFIDASE
    2024-516727-13-00 1 country 2023 n=10
    Recruiting

Phase IV

1 trial
  • Assistance Publique Hopitaux De Paris Academic
    RITUXIMAB
    2025-522049-23-00 1 country n=70
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 1 Phase II 0
Charite Universitaetsmedizin Berlin KöR Academic 1 Phase II 1
Assistance Publique Hopitaux De Paris Academic 1 Phase IV 0
New trials by year
2023
1
2024
1
← All indication landscapes